 <h1>Makena Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>hydroxyprogesterone</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about hydroxyprogesterone. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Makena.</p><h2>In Summary</h2><p><b>Common side effects of Makena include:</b> urticaria and swelling at injection site. <b>Other side effects include:</b> pruritus.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to hydroxyprogesterone: parenteral injection for im use</i></p><p>Side effects include:</p><p>Injection site reactions (pain, swelling, pruritus, nodule), urticaria, pruritus, nausea, diarrhea. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hydroxyprogesterone: compounding powder, intramuscular solution, subcutaneous solution</i></p><h3>General</h3><p>The most commonly reported adverse reaction is injection site pain.</p><h3>Local</h3><p>Injection site cellulitis was reported in 1 subject.  In a study that compared IM injection to subcutaneous auto-injector, injection site pain was reported in 10% of subjects receiving drug via the auto-injector compared with 7% receiving an IM injection.  In a second study, 34% reported injection site pain with the auto-injector and 8% with IM injection.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Injection site pain (up to 34.8%), injection site swelling (up to 17.1%) </p><p><b>Common</b> (1% to 10%): Injection site pruritus, injection site nodules</p><p><b>Frequency not reported</b>: Injection site cellulitis </p><p><b>Postmarketing reports</b>: Local injection site reactions of erythema, urticaria, rash, irritation, hypersensitivity, warmth<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Pregnancy complications</p><p><b>Postmarketing reports</b>: Cervical incompetence, premature rupture of membranes</p><p>Certain pregnancy-related fetal and maternal complications or events were numerically increased in patients receiving this drug compared with placebo including miscarriage at less than 20 weeks (5/209 vs 0/107), stillbirth (6/302 vs 2/153), admission for preterm labor (16% vs 13.8%), preeclampsia or gestation hypertension (8.8% vs 4.6%), gestational diabetes (5.6% vs 4.6%), and oligohydramnios (3.6% vs 1.3%).</p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Admission for preterm labor, preeclampsia or gestational hypertension, gestational diabetes, oligohydramnios</p><p><b>Postmarketing reports</b>: Urinary tract infection, cervical incompetence, premature rupture of membranes, cervical dilation, shortened cervix<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea</p><p><b>Postmarketing reports</b>: Vomiting<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Urticaria (12.3%) </p><p><b>Common</b> (1% to 10%): Pruritus</p><p><b>Postmarketing reports</b>: Rash<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Postmarketing reports</b>: Headache, dizziness</p><h3>Respiratory</h3><p>Pulmonary embolus was reported in 1 patient.</p><p><b>Frequency not reported</b>: Pulmonary embolus </p><p><b>Postmarketing reports</b>: Dyspnea, chest discomfort</p><h3>Other</h3><p><b>Postmarketing reports</b>: Fatigue, fever, hot flashes/flushes</p><p id="ref_1">1. "Product Information. Makena (hydroxyprogesterone)." Ther-Rx Corporation, Bridgeton, MO. </p><h2>More about Makena (hydroxyprogesterone)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>141 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: progestins</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Makena Auto-Injector</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Premature Labor</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>